Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (3521)	7/30/1999 8:30:00 PM
From: Herc	Read Replies (2) \| Respond to of 10280

New to the thread. Would someone please explain why SEPR warrants a price/sales of 144 when ABSC, ARQL, BCRX, CCHM, PCOP, & TRGA average less than 4? Also SEPR's sales are still anemic, and their sales growth over last year ranked dead last. I divided the sales growth by the price sales ratio and CCHM was the winner @ 37; SEPR was 0.9. Did SEPR just catch on and build momentum? Are you all in love with the stock? Where are the great results? 'Splain it to me. BEFUDDLED IN NEW ORLEANS.